Page last updated: 2024-08-16

resveratrol and Heart Disease, Ischemic

resveratrol has been researched along with Heart Disease, Ischemic in 41 studies

Research

Studies (41)

Timeframe	Studies, this research(%)	All Research%
pre-1990	0 (0.00)	18.7374
1990's	1 (2.44)	18.2507
2000's	17 (41.46)	29.6817
2010's	19 (46.34)	24.3611
2020's	4 (9.76)	2.80

Authors

Authors	Studies
Lu, J; Ma, Y; Sun, L; Wang, S; Xue, P; Yu, J; Yue, X; Zhang, Y	1
Chen, H; Liu, H; Liu, S; Ren, J; Tang, L; Wang, X; Zhao, X; Zhou, T	1
Guan, P; Ji, ES; Luo, LF; Qin, LY; Sun, ZM; Wang, N; Zhao, YS	1
Bian, ZY; Ding, W; Feng, H; Li, WJ; Liao, HH; Mou, SQ; Zhang, N; Zhou, ZY	1
Chen, HP; Deng, YZ; Li, XR; Liu, HY; Ma, ZX; Qiu, LJ; Xu, RY; Xu, XW; Zhao, L	1
Dalal, RS; Elmadhun, NY; Robich, MP; Sabe, AA; Sellke, FW	2
Das, DK; Das, S; Mitrovsky, G; Vasanthi, HR	1
Bianchi, C; Dalal, RS; Elmadhun, NY; Robich, MP; Sabe, AA; Sadek, AA; Sellke, FW	1
Cao, F; Chen, Y; Han, D; Ma, S; Wang, J	1
Amadio, P; Banfi, C; Barbieri, SS; Brioschi, M; Colombo, GI; Gianellini, S; Ieraci, A; Lee, FS; Parolari, A; Tarantino, E; Tremoli, E; Werba, JP	1
Chih, CL; Hu, BR; Huang, SS; Lin, JF; Lin, SM; Nien, MW; Su, HH; Tsai, SK	1
Das, DK; Das, S; Dudley, J; Mukherjee, S	1
Bertelli, AA; Das, DK; Das, M; Dudley, JI; Lekli, I; Mukherjee, S	1
Cacciapuoti, F	1
Chen, CJ; Fu, YC; Li, JL; Wang, W; Wang, X; Yu, W	1
Bianchi, C; Sellke, FW; Wykrzykowska, JJ	1
Chaudray, M; Chu, LM; Clements, RT; Coady, MA; Han, Y; Laham, RJ; Manning, WJ; Nezafat, R; Robich, MP; Sellke, FW	1
Bernhagen, J; Bucala, R; Leng, L; Li, J; Ma, H; Merk, M; Ren, J; Thomas, DP; Tong, C; Wang, J; Wang, W; Zierow, S	1
Bianchi, C; Boodhwani, M; Clements, RT; Coady, MA; Feng, J; Laham, RJ; Nezafat, R; Osipov, RM; Robich, MP; Sellke, FW	1
Das, DK; Gesztelyi, R; Juhasz, A; Juhasz, B; Juhaz, B; Kertesz, A; Varga, B	1
Ahsan, K; Bagchi, A; Das, DK; Mukherjee, S; Mukhopadhyay, P; Pacher, P	1
Das, DK; Mukhopadhyay, P; Pacher, P	1
Chu, LM; Clements, RT; Feng, J; Han, Y; Manning, WJ; Nezafat, R; Osipov, RM; Robich, MP; Sellke, FW	1
Burgess, T; Chu, LM; Clements, RT; Feng, J; Laham, RJ; Lassaletta, AD; Robich, MP; Sellke, FW	1
Ahsan, MK; Das, DK; Das, S; Mukhopadhyay, P; Otani, H	1
Burgess, TA; Chu, LM; Feng, J; Han, Y; Laham, RJ; Leber, MP; Manning, WJ; Nezafat, R; Robich, MP; Sellke, FW	1
Bin, J; Chen, B; Chen, C; Liao, Y; Wu, B; Xu, D; Xuan, W; Zhang, W	1
Forini, F; Iervasi, G; Sabatino, L	1
Barenghi, L; Beemster, P; Bertelli, AA; Bradamante, S; De Jong, JW; De Jonge, R; Piccinini, F	2
Dernek, S; Ergun, B; Erkasap, N; Ikizler, M; Kaygisiz, Z; Koken, T; Kural, T; Sevin, B; Yilmaz, K	1
Cingolani, HE; Fantinelli, JC; Mosca, SM; Schinella, G	1
Akar, F; Aslamaci, S; Coskun, B; Kiziltepe, U; Rakici, O	1
Bagchi, D; Das, DK; Das, S; Maulik, N; Tosaki, A	1
Jia, GL; Ma, H; Shen, M; Wang, YM	1
Bertelli, A; Bertelli, AA; Cordis, GA; Das, DK; Maulik, G; Ray, PS	1
Bagchi, D; Das, DK; Maulik, G; Sato, M	1
Chen, JK; Huang, SS; Hung, LM; Lee, RS; Su, MJ	1
Chan, WF; Chen, JK; Chiao, CW; Chu, WK; Hung, LM; Su, MJ	1
Das, DK; Hattori, R; Maulik, N; Otani, H	1

Reviews

4 review(s) available for resveratrol and Heart Disease, Ischemic

Article	Year
SIRT1 as a Promising Novel Therapeutic Target for Myocardial Ischemia Reperfusion Injury and Cardiometabolic Disease. Current drug targets, 2017, Volume: 18, Issue:15 Topics: Animals; Apoptosis; Disease Models, Animal; Heterocyclic Compounds, 4 or More Rings; Humans; Metabolic Diseases; Molecular Targeted Therapy; Myocardial Ischemia; Myocardial Reperfusion Injury; Myocytes, Cardiac; Resveratrol; Sirtuin 1; Stilbenes; Transcriptional Activation	2017
Opposite effects of metabolic syndrome and calorie restriction on thrombotic disease: heads and tails of the same coin--resveratrol's role. Metabolic syndrome and related disorders, 2009, Volume: 7, Issue:5 Topics: Animals; Blood Coagulation; Caloric Restriction; Fibrinolytic Agents; Humans; Metabolic Syndrome; Myocardial Ischemia; Resveratrol; Sirtuins; Stilbenes; Thrombosis; Ventricular Function, Left; Wine	2009
Impact of aging on the angiogenic potential of the myocardium: implications for angiogenic therapies with emphasis on sirtuin agonists. Recent patents on cardiovascular drug discovery, 2009, Volume: 4, Issue:2 Topics: Aging; Angiogenesis Inducing Agents; Angiogenesis Inhibitors; Animals; Collateral Circulation; Coronary Vessels; Humans; Myocardial Ischemia; Resveratrol; Sirtuins; Stilbenes	2009
MicroRNA signatures of resveratrol in the ischemic heart. Annals of the New York Academy of Sciences, 2011, Volume: 1215 Topics: Animals; Humans; MicroRNAs; Myocardial Ischemia; Resveratrol; Stilbenes	2011

Trials

1 trial(s) available for resveratrol and Heart Disease, Ischemic

Article	Year
Effects of resveratrol on vascular tone and endothelial function of human saphenous vein and internal mammary artery. International journal of cardiology, 2005, Nov-02, Volume: 105, Issue:2 Topics: Acetylcholine; Antioxidants; Coronary Artery Bypass; Endothelium, Vascular; Female; Follow-Up Studies; Humans; In Vitro Techniques; Indomethacin; Male; Mammary Arteries; Middle Aged; Myocardial Ischemia; Norepinephrine; Resveratrol; Saphenous Vein; Stilbenes; Vasoconstrictor Agents; Vasodilation; Vasodilator Agents	2005

Article

Year

Effects of resveratrol on vascular tone and endothelial function of human saphenous vein and internal mammary artery.

International journal of cardiology, 2005, Nov-02, Volume: 105, Issue:2

Topics: Acetylcholine; Antioxidants; Coronary Artery Bypass; Endothelium, Vascular; Female; Follow-Up Studies; Humans; In Vitro Techniques; Indomethacin; Male; Mammary Arteries; Middle Aged; Myocardial Ischemia; Norepinephrine; Resveratrol; Saphenous Vein; Stilbenes; Vasoconstrictor Agents; Vasodilation; Vasodilator Agents

2005

Other Studies

36 other study(ies) available for resveratrol and Heart Disease, Ischemic

Article	Year
Establishment of fingerprint and mechanism of anti-myocardial ischemic effect of Syringa pinnatifolia. Biomedical chromatography : BMC, 2022, Volume: 36, Issue:11 Topics: Animals; bcl-2-Associated X Protein; Caspase 3; Creatine Kinase; Eosine Yellowish-(YS); Flavonoids; Hematoxylin; Isoenzymes; Lactate Dehydrogenases; Myocardial Infarction; Myocardial Ischemia; Myocardium; Myocytes, Cardiac; Plant Extracts; Proto-Oncogene Proteins c-bcl-2; Rats; Resveratrol; Syringa; Terpenes	2022
Resveratrol inhibits autophagy against myocardial ischemia-reperfusion injury through the DJ-1/MEKK1/JNK pathway. European journal of pharmacology, 2023, Jul-15, Volume: 951 Topics: Animals; Apoptosis; Autophagy; MAP Kinase Kinase Kinases; MAP Kinase Signaling System; Myocardial Ischemia; Myocardial Reperfusion Injury; Myocytes, Cardiac; Rats; Resveratrol	2023
Resveratrol protects against CIH-induced myocardial injury by targeting Nrf2 and blocking NLRP3 inflammasome activation. Life sciences, 2020, Mar-15, Volume: 245 Topics: Animals; Antioxidants; Blotting, Western; Echocardiography; Fluorescent Antibody Technique; Hypoxia; Inflammasomes; Male; Myocardial Ischemia; NF-E2-Related Factor 2; NLR Family, Pyrin Domain-Containing 3 Protein; Oxidative Stress; Rats; Rats, Sprague-Dawley; Real-Time Polymerase Chain Reaction; Resveratrol	2020
Resveratrol Inhibits Ischemia-Induced Myocardial Senescence Signals and NLRP3 Inflammasome Activation. Oxidative medicine and cellular longevity, 2020, Volume: 2020 Topics: Animals; Apoptosis; Biomarkers; Cell Hypoxia; Heart Function Tests; Inflammasomes; Male; Mice, Inbred C57BL; Myocardial Ischemia; Myocardium; Myocytes, Cardiac; NLR Family, Pyrin Domain-Containing 3 Protein; Rats, Sprague-Dawley; Resveratrol; Risk Factors; Signal Transduction	2020
Resveratrol attenuates myocardial hypoxia/reoxygenation-induced cell apoptosis through DJ-1-mediated SIRT1-p53 pathway. Biochemical and biophysical research communications, 2019, 06-25, Volume: 514, Issue:2 Topics: Acetylation; Animals; Apoptosis; Cardiotonic Agents; Cell Hypoxia; Cell Line; Cell Survival; Enzyme Activation; L-Lactate Dehydrogenase; Myocardial Ischemia; Myocardial Reperfusion Injury; Protein Binding; Protein Deglycase DJ-1; Rats; Resveratrol; Sirtuin 1; Tumor Suppressor Protein p53	2019
Does resveratrol improve insulin signaling in chronically ischemic myocardium? The Journal of surgical research, 2013, Volume: 183, Issue:2 Topics: AMP-Activated Protein Kinases; Animals; Apoptosis; Cardiotonic Agents; Disease Models, Animal; Glucose; Insulin; Male; Metabolic Syndrome; Myocardial Ischemia; Myocardium; Resveratrol; Signal Transduction; Stilbenes; Swine	2013
Resveratrol regulates autophagy signaling in chronically ischemic myocardium. The Journal of thoracic and cardiovascular surgery, 2014, Volume: 147, Issue:2 Topics: Animals; Apoptosis Regulatory Proteins; Autophagy; Blotting, Western; Cholesterol, Dietary; Diet, High-Fat; Disease Models, Animal; Lysosomal-Associated Membrane Protein 2; Male; Microtubule-Associated Proteins; Myocardial Ischemia; Myocardium; Phosphorylation; Resveratrol; Ribosomal Protein S6 Kinases, 70-kDa; Signal Transduction; Stilbenes; Swine; Swine, Miniature; Time Factors; TOR Serine-Threonine Kinases	2014
Antiaging properties of a grape-derived antioxidant are regulated by mitochondrial balance of fusion and fission leading to mitophagy triggered by a signaling network of Sirt1-Sirt3-Foxo3-PINK1-PARKIN. Oxidative medicine and cellular longevity, 2014, Volume: 2014 Topics: Aging; Animals; Antioxidants; Apoptosis; Blotting, Western; Fluorescent Antibody Technique; Forkhead Box Protein O3; Forkhead Transcription Factors; Glutathione; Heart Ventricles; In Vitro Techniques; Intracellular Space; Male; Mitochondrial Dynamics; Mitophagy; Myocardial Infarction; Myocardial Ischemia; Myocardium; Myocytes, Cardiac; Protein Kinases; Rats; Rats, Sprague-Dawley; Reactive Oxygen Species; Resveratrol; Signal Transduction; Sirtuins; Stilbenes; Ubiquitin-Protein Ligases; Vitis	2014
Investigating the effects of resveratrol on chronically ischemic myocardium in a swine model of metabolic syndrome: a proteomics analysis. Journal of medicinal food, 2015, Volume: 18, Issue:1 Topics: Animals; Antioxidants; Biomarkers; Cell Death; Cholesterol, Dietary; Coronary Vessels; Dietary Supplements; Disease Models, Animal; Heart; Male; Metabolic Syndrome; Mitochondria; Myocardial Ischemia; Myocardium; Phytotherapy; Plant Extracts; Proteins; Proteomics; Resveratrol; Signal Transduction; Stilbenes; Swine	2015
BDNFVal66met polymorphism: a potential bridge between depression and thrombosis. European heart journal, 2017, May-07, Volume: 38, Issue:18 Topics: Animals; Anxiety Disorders; Aorta; Blood Coagulation; Brain-Derived Neurotrophic Factor; Carotid Arteries; Carotid Artery Thrombosis; Depressive Disorder; Disease Models, Animal; Female; Heterozygote; Homozygote; Humans; Male; Mice, Transgenic; Middle Aged; Myocardial Ischemia; Nerve Tissue Proteins; Platelet Activation; Platelet Aggregation Inhibitors; Polymorphism, Single Nucleotide; Receptors, Cell Surface; Resveratrol; Signal Transduction; Sirtuin 1; Stilbenes; Thrombosis	2017
Resveratrol reduces infarct size and improves ventricular function after myocardial ischemia in rats. Life sciences, 2008, Aug-29, Volume: 83, Issue:9-10 Topics: Animals; Antioxidants; Atrial Natriuretic Factor; Collagen Type I; Echocardiography; Hemodynamics; Male; Mice; Myocardial Ischemia; Random Allocation; Rats; Rats, Sprague-Dawley; Resveratrol; Stilbenes; Transforming Growth Factor beta1; Ventricular Remodeling	2008
Resveratrol, a unique phytoalexin present in red wine, delivers either survival signal or death signal to the ischemic myocardium depending on dose. The Journal of nutritional biochemistry, 2009, Volume: 20, Issue:6 Topics: Animals; Antineoplastic Agents, Phytogenic; Apoptosis; Cell Survival; Dose-Response Relationship, Drug; Down-Regulation; Male; Myocardial Ischemia; NF-kappa B; Oxidation-Reduction; Phytoalexins; Rats; Rats, Sprague-Dawley; Resveratrol; Sesquiterpenes; Signal Transduction; Stilbenes; Terpenes; Wine	2009
Does white wine qualify for French paradox? Comparison of the cardioprotective effects of red and white wines and their constituents: resveratrol, tyrosol, and hydroxytyrosol. Journal of agricultural and food chemistry, 2008, Oct-22, Volume: 56, Issue:20 Topics: Animals; Apoptosis; Apoptosis Regulatory Proteins; Cardiotonic Agents; Heart; Humans; In Vitro Techniques; Male; Mitochondrial Swelling; Myocardial Ischemia; Myocardium; Peroxides; Phenylethyl Alcohol; Random Allocation; Rats; Rats, Sprague-Dawley; Resveratrol; Stilbenes; Wine	2008
Resveratrol protects cardiomyocytes from hypoxia-induced apoptosis through the SIRT1-FoxO1 pathway. Biochemical and biophysical research communications, 2009, Jan-16, Volume: 378, Issue:3 Topics: Animals; Antioxidants; Apoptosis; Cell Hypoxia; Cells, Cultured; Cytoprotection; Forkhead Transcription Factors; Myocardial Ischemia; Myocytes, Cardiac; Nerve Tissue Proteins; Rats; Resveratrol; Sirtuin 1; Sirtuins; Stilbenes	2009
Anti-angiogenic effect of high-dose resveratrol in a swine model of metabolic syndrome. Surgery, 2010, Volume: 148, Issue:2 Topics: Angiogenesis Inhibitors; Angiostatins; Animals; Antigens, CD; Cadherins; Cholesterol, Dietary; Collateral Circulation; Coronary Angiography; Disease Models, Animal; Magnetic Resonance Imaging; Male; Metabolic Syndrome; Myocardial Ischemia; Neovascularization, Physiologic; Resveratrol; Stilbenes; Swine; Swine, Miniature	2010
Impaired macrophage migration inhibitory factor-AMP-activated protein kinase activation and ischemic recovery in the senescent heart. Circulation, 2010, Jul-20, Volume: 122, Issue:3 Topics: Aging; AMP-Activated Protein Kinases; Animals; Down-Regulation; Enzyme Inhibitors; Hypoxia-Inducible Factor 1, alpha Subunit; Intramolecular Oxidoreductases; Macrophage Migration-Inhibitory Factors; Mice; Mice, Knockout; Myocardial Infarction; Myocardial Ischemia; Myocardium; Myocytes, Cardiac; Phenotype; Phosphorylation; Resveratrol; Signal Transduction; Stilbenes; Ultrasonography; Ventricular Function, Left	2010
Resveratrol improves myocardial perfusion in a swine model of hypercholesterolemia and chronic myocardial ischemia. Circulation, 2010, Sep-14, Volume: 122, Issue:11 Suppl Topics: Animals; Anti-Inflammatory Agents, Non-Steroidal; Capillaries; Chronic Disease; Coronary Circulation; Coronary Disease; Disease Models, Animal; Female; Humans; Hypercholesterolemia; Male; Microcirculation; Myocardial Ischemia; Myocardium; Neovascularization, Physiologic; Perfusion; Resveratrol; Signal Transduction; Stilbenes; Swine; Vascular Endothelial Growth Factor A	2010
Reduction of blood cholesterol and ischemic injury in the hypercholesteromic rabbits with modified resveratrol, longevinex. [corrected] Molecular and cellular biochemistry, 2011, Volume: 348, Issue:1-2 Topics: Animals; Anticholesteremic Agents; Arteriosclerosis; Biomarkers; Cholesterol; Disease Models, Animal; Down-Regulation; Hemodynamics; Hypercholesterolemia; Male; Myocardial Infarction; Myocardial Ischemia; Myocardial Reperfusion Injury; Myocardium; Rabbits; Resveratrol; Stilbenes; Time Factors; Ventricular Function, Left; Ventricular Pressure	2011
Restoration of altered microRNA expression in the ischemic heart with resveratrol. PloS one, 2010, Dec-23, Volume: 5, Issue:12 Topics: Animals; Cardiotonic Agents; Computational Biology; Heart; Male; Mice; MicroRNAs; Myocardial Ischemia; Rats; Rats, Sprague-Dawley; Reperfusion Injury; Resveratrol; Reverse Transcriptase Polymerase Chain Reaction; Software; Stilbenes	2010
Resveratrol modifies risk factors for coronary artery disease in swine with metabolic syndrome and myocardial ischemia. European journal of pharmacology, 2011, Aug-16, Volume: 664, Issue:1-3 Topics: Animals; Biomarkers; Cholesterol; Coronary Artery Disease; Diet; Dietary Supplements; Fatty Acids, Nonesterified; Gene Expression Regulation; Glucose Tolerance Test; Glucose Transporter Type 4; Heart; Inflammation; Insulin; Magnetic Resonance Imaging; Metabolic Syndrome; Microvessels; Muscle Cells; Myocardial Ischemia; Oxidation-Reduction; Protein Transport; Resveratrol; Risk Factors; Stilbenes; Swine	2011
Resveratrol supplementation abrogates pro-arteriogenic effects of intramyocardial vascular endothelial growth factor in a hypercholesterolemic swine model of chronic ischemia. Surgery, 2011, Volume: 150, Issue:3 Topics: Administration, Oral; Animals; Blood Chemical Analysis; Coronary Angiography; Coronary Circulation; Disease Models, Animal; Drug Therapy, Combination; Hypercholesterolemia; Immunoblotting; Immunohistochemistry; Male; Myocardial Ischemia; Neovascularization, Physiologic; Oxidative Stress; Phosphorylation; Random Allocation; Reference Values; Resveratrol; Risk Factors; Sensitivity and Specificity; Stilbenes; Swine; Vascular Endothelial Growth Factor A	2011
Modulation of microRNA 20b with resveratrol and longevinex is linked with their potent anti-angiogenic action in the ischaemic myocardium and synergestic effects of resveratrol and γ-tocotrienol. Journal of cellular and molecular medicine, 2012, Volume: 16, Issue:10 Topics: Angiogenesis Inhibitors; Animals; Apoptosis; Chromans; Down-Regulation; Drug Synergism; Gene Expression Profiling; Heart; Hypoxia-Inducible Factor 1, alpha Subunit; Male; MicroRNAs; Microscopy, Confocal; Multivariate Analysis; Myocardial Ischemia; Myocardium; Rats; Rats, Sprague-Dawley; Reactive Oxygen Species; Resveratrol; Signal Transduction; Stilbenes; Vascular Endothelial Growth Factor A; Vitamin E	2012
Resveratrol preserves myocardial function and perfusion in remote nonischemic myocardium in a swine model of metabolic syndrome. Journal of the American College of Surgeons, 2012, Volume: 215, Issue:5 Topics: Animals; Antioxidants; Biomarkers; Blotting, Western; Coronary Vessels; Diet, High-Fat; Disease Models, Animal; Fluorescent Antibody Technique; Heart; Magnetic Resonance Imaging; Metabolic Syndrome; Myocardial Ischemia; Myocardium; Oxidative Stress; Resveratrol; Stilbenes; Swine; Ventricular Function, Left	2012
Resveratrol improves myocardial ischemia and ischemic heart failure in mice by antagonizing the detrimental effects of fractalkine. Critical care medicine, 2012, Volume: 40, Issue:11* Topics: Animals; Animals, Newborn; Chemokine CX3CL1; Disease Models, Animal; Electrocardiography; Heart Failure; Male; Mice; Mice, Inbred C57BL; Myocardial Ischemia; Platelet Aggregation Inhibitors; Random Allocation; Rats; Resveratrol; Stilbenes; Ventricular Remodeling	2012
A glass of wine: how good is good? The resveratrol lesson. Critical care medicine, 2012, Volume: 40, Issue:11* Topics: Animals; Chemokine CX3CL1; Heart Failure; Male; Myocardial Ischemia; Platelet Aggregation Inhibitors; Resveratrol; Stilbenes	2012
Resveratrol provides late-phase cardioprotection by means of a nitric oxide- and adenosine-mediated mechanism. European journal of pharmacology, 2003, Mar-28, Volume: 465, Issue:1-2 Topics: Adenosine; Animals; Cardiotonic Agents; Coronary Circulation; Enzyme Inhibitors; Heart; In Vitro Techniques; Male; Myocardial Ischemia; Myocardial Reperfusion Injury; Myocardium; NG-Nitroarginine Methyl Ester; Nitric Oxide; Nitric Oxide Synthase; Purinergic P1 Receptor Antagonists; Rats; Rats, Sprague-Dawley; Resveratrol; Stilbenes; Theophylline; Time Factors; Vasodilator Agents	2003
Cardioprotection with resveratrol pretreatment: improved beneficial effects over standard treatment in rat hearts after global ischemia. Scandinavian cardiovascular journal : SCJ, 2004, Volume: 38, Issue:4 Topics: Analysis of Variance; Animals; Coronary Circulation; Disease Models, Animal; Hemodynamics; Ischemic Preconditioning, Myocardial; Male; Myocardial Ischemia; Myocardial Reperfusion; Myocardial Reperfusion Injury; Probability; Random Allocation; Rats; Rats, Sprague-Dawley; Resveratrol; Sensitivity and Specificity; Stilbenes; Survival Rate	2004
Effects of different fractions of a red wine non-alcoholic extract on ischemia-reperfusion injury. Life sciences, 2005, Apr-22, Volume: 76, Issue:23 Topics: Animals; Argentina; Blood Pressure; Cardiotonic Agents; Flavonols; L-Lactate Dehydrogenase; Lipid Peroxidation; Male; Myocardial Ischemia; Myocardial Reperfusion Injury; Phenols; Rats; Rats, Wistar; Resveratrol; Stilbenes; Thiobarbituric Acid Reactive Substances; Ventricular Function, Left; Wine	2005
Potentiation of a survival signal in the ischemic heart by resveratrol through p38 mitogen-activated protein kinase/mitogen- and stress-activated protein kinase 1/cAMP response element-binding protein signaling. The Journal of pharmacology and experimental therapeutics, 2006, Volume: 317, Issue:3 Topics: Animals; Cardiotonic Agents; Cyclic AMP Response Element-Binding Protein; Enzyme Inhibitors; In Vitro Techniques; Male; Mitogen-Activated Protein Kinase 1; Mitogen-Activated Protein Kinase 8; Mitogen-Activated Protein Kinases; Myocardial Infarction; Myocardial Ischemia; Myocardium; p38 Mitogen-Activated Protein Kinases; Phosphorylation; Rats; Rats, Sprague-Dawley; Resveratrol; Signal Transduction; Stilbenes	2006
Cardioprotective effect of resvaratrol pretreatment on myocardial ischemia-reperfusion induced injury in rats. Vascular pharmacology, 2006, Volume: 45, Issue:2 Topics: Animals; Antioxidants; Cardiotonic Agents; Free Radical Scavengers; Male; Myocardial Ischemia; Myocardial Reperfusion Injury; Nitric Oxide; Rats; Rats, Sprague-Dawley; Resveratrol; Stilbenes; Up-Regulation	2006
The red wine antioxidant resveratrol protects isolated rat hearts from ischemia reperfusion injury. Free radical biology & medicine, 1999, Volume: 27, Issue:1-2 Topics: Animals; Antioxidants; Free Radicals; Heart; In Vitro Techniques; Male; Malondialdehyde; Myocardial Infarction; Myocardial Ischemia; Myocardial Reperfusion Injury; Peroxides; Rats; Rats, Sprague-Dawley; Resveratrol; Stilbenes; Wine	1999
Myocardial protection by protykin, a novel extract of trans-resveratrol and emodin. Free radical research, 2000, Volume: 32, Issue:2 Topics: Animals; Antioxidants; Blood Pressure; Coronary Vessels; Emodin; Fluoresceins; Free Radical Scavengers; Gamma Rays; Hydroxyl Radical; Male; Malondialdehyde; Myocardial Infarction; Myocardial Ischemia; Oxidative Stress; Peroxides; Polygonaceae; Rats; Rats, Sprague-Dawley; Reperfusion Injury; Resveratrol; Stilbenes	2000
Does resveratrol induce pharmacological preconditioning? International journal of tissue reactions, 2000, Volume: 22, Issue:1 Topics: Adenosine; Animals; Antioxidants; Cardiovascular Physiological Phenomena; Heart; Ischemic Preconditioning, Myocardial; Male; Muscle Contraction; Myocardial Infarction; Myocardial Ischemia; Myocardium; Phosphates; Phosphorylation; Rats; Rats, Sprague-Dawley; Recovery of Function; Regional Blood Flow; Reperfusion Injury; Resveratrol; Stilbenes	2000
Cardioprotective effect of resveratrol, a natural antioxidant derived from grapes. Cardiovascular research, 2000, Aug-18, Volume: 47, Issue:3 Topics: Analysis of Variance; Animals; Antioxidants; Blood Pressure; Chi-Square Distribution; Free Radical Scavengers; Heart Rate; L-Lactate Dehydrogenase; Male; Myocardial Ischemia; Myocardial Reperfusion Injury; Nitric Oxide; Rats; Rats, Sprague-Dawley; Resveratrol; Statistics, Nonparametric; Stilbenes; Tachycardia, Ventricular; Ventricular Fibrillation	2000
The protective effect of resveratrols on ischaemia-reperfusion injuries of rat hearts is correlated with antioxidant efficacy. British journal of pharmacology, 2002, Volume: 135, Issue:7 Topics: Animals; Biphenyl Compounds; Disease Models, Animal; Free Radical Scavengers; Humans; Lipoproteins, LDL; Male; Myocardial Ischemia; Oxidation-Reduction; Picrates; Protective Agents; Rats; Rats, Inbred WKY; Reperfusion Injury; Resveratrol; Stilbenes; Superoxides	2002
Pharmacological preconditioning with resveratrol: role of nitric oxide. American journal of physiology. Heart and circulatory physiology, 2002, Volume: 282, Issue:6 Topics: Animals; Apoptosis; Enzyme Inhibitors; Gene Expression; Guanidines; Heart Ventricles; Ischemic Preconditioning; Malondialdehyde; Myocardial Infarction; Myocardial Ischemia; Myocardial Reperfusion Injury; Myocardium; NG-Nitroarginine Methyl Ester; Nitric Oxide; Nitric Oxide Synthase; Nitric Oxide Synthase Type II; Rats; Rats, Sprague-Dawley; Resveratrol; RNA, Messenger; Stilbenes	2002